“All About New Options for Men with Advanced Prostate Cancer – Treatments, Immunotherapy & Clinical Trials”
This conference is with James L. Gulley, M.D., Ph.D., F.A.C.P. is Director, Clinical Trials Group and Deputy Chief, Laboratory of Tumor Immunology and Biology as well as the Senior Investigator iin the Medical Oncology Branch of the Center for Cancer Research, National Cancer Institute National Institutes of Health. He is interviewed by Joel Nowak, M.A., MSW, Director of Malecare Advanced Disease and Advocacy. This teleconference presents an overview of the new treatments now available for men with castrate resistant advanced prostate cancer including a discussion of the sequencing and combining of these treatments. They also talk about immunotherapies and their role in current treatment. This conference was recorded in May of 2013

“All About Provenge”
Joel Nowak, MA, MSW, Director of Malecare Advanced Disease and Advocacy will be speaking with Neal Shore, MD. Dr. Shore is affiliated with the Carolina Urologic Research Center, Linked Urology Research Network and Uropath and is using Provenge with advanced prostate cancer patients. This conference was recorded in early 2012

“All About Advanced Prostate Cancer”
Dr. McKiernan is Vice Chairman of the Department and Director of Urologic Oncology at New York – Presbyterian Hospital/Columbia University Medical Center. He treats many patients with high risk cancer diagnoses. He is interviewed by Joel Nowak, M.A., MSW, Director of Malecare Advanced Disease and Advocacy.

Dr. McKiernan is actively involved with ongoing research programs focused on improving patient outcomes. He has authored and co-authored more than 80 articles, book chapters, and abstracts in the field of urologic oncology. His research and discoveries have been published in Urology, Journal of Urology, Journal of Clinical Oncology, Cancer, and Cancer Research. This conference was recorded August 17, 2010